{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:29:46Z","timestamp":1792045786154,"version":"4.4.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS115290"],"award-info":[{"award-number":["NS115290"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS110749"],"award-info":[{"award-number":["R01NS110749"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R16NS134540-01"],"award-info":[{"award-number":["R16NS134540-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG072464"],"award-info":[{"award-number":["U01AG072464"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03AG081865-01"],"award-info":[{"award-number":["R03AG081865-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Albany Medical College","award":["Startup Funds"],"award-info":[{"award-number":["Startup Funds"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["946666"],"award-info":[{"award-number":["946666"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is notably associated with cognitive decline resulting from impaired function of hippocampal and cortical areas; however, several other domains and corresponding brain regions are affected. One such brain region is the hypothalamus, shown to atrophy and develop amyloid and tau pathology in AD patients. The hypothalamus controls several functions necessary for survival, including energy and glucose homeostasis. Changes in appetite and body weight are common in AD, often seen several years prior to the onset of cognitive symptoms. Therefore, altered metabolic processes may serve as a biomarker for AD, as well as a target for treatment, considering they are likely both a result of pathological changes and contributor to disease progression. Previously, we reported sexually dimorphic metabolic disturbances in\u2009~\u20097-month-old 3xTg-AD mice, accompanied by differences in systemic and hypothalamic inflammation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the current study, we investigated metabolic outcomes and hypothalamic inflammation in 3xTg-AD males and females at 3, 6, 9, and 12\u00a0months of age to determine when these sex differences emerge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In agreement with our previous study, AD males displayed less weight gain and adiposity, as well as reduced blood glucose levels following a glucose challenge, compared to females. These trends were apparent by 6\u20139\u00a0months of age, coinciding with increased expression of inflammatory markers (Iba1, GFAP, TNF-\u03b1, and IL-1\u03b2) in the hypothalamus of AD males.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings provide additional evidence for sex-dependent effects of AD pathology on energy and glucose homeostasis, which may be linked to hypothalamic inflammation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13293-023-00536-5","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T04:02:40Z","timestamp":1691553760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-9183","authenticated-orcid":false,"given":"Lisa S.","family":"Robison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia J.","family":"Gannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail E.","family":"Salinero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Abi-Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febronia M.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5395-7362","authenticated-orcid":false,"given":"Kristen L.","family":"Zuloaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"536_CR1","doi-asserted-by":"crossref","unstructured":"World Health Organization. Global status report on the public health response to dementia. 2021.","DOI":"10.1016\/S2468-2667(21)00215-2"},{"issue":"1","key":"536_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","volume":"9","author":"M Prince","year":"2013","unstructured":"Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer\u2019s Dementia. 2013;9(1):63-75.e2.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"5","key":"536_CR3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cmet.2015.08.016","volume":"22","author":"M Ishii","year":"2015","unstructured":"Ishii M, Iadecola C. Metabolic and non-cognitive manifestations of Alzheimer\u2019s disease: the hypothalamus as both culprit and target of pathology. Cell Metab. 2015;22(5):761\u201376.","journal-title":"Cell Metab"},{"issue":"27","key":"536_CR4","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1523\/JNEUROSCI.0872-14.2014","volume":"34","author":"M Ishii","year":"2014","unstructured":"Ishii M, Wang G, Racchumi G, Dyke JP, Iadecola C. Transgenic mice overexpressing amyloid precursor protein exhibit early metabolic deficits and a pathologically low leptin state associated with hypothalamic dysfunction in arcuate neuropeptide Y neurons. J Neurosci. 2014;34(27):9096\u2013106.","journal-title":"J Neurosci"},{"issue":"3","key":"536_CR5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.3390\/ijms21030843","volume":"21","author":"LS Robison","year":"2020","unstructured":"Robison LS, Francis N, Popescu DL, Anderson ME, Hatfield J, Xu F, et al. Environmental enrichment: disentangling the influence of novelty, social, and physical activity on cerebral amyloid angiopathy in a transgenic mouse model. Int J Mol Sci. 2020;21(3):843.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"536_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-020-01956-5","volume":"17","author":"LS Robison","year":"2020","unstructured":"Robison LS, Gannon OJ, Thomas MA, Salinero AE, Abi-Ghanem C, Poitelon Y, et al. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2020;17(1):1\u201320.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"536_CR7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-019-1534-0","volume":"16","author":"LS Robison","year":"2019","unstructured":"Robison LS, Popescu DL, Anderson ME, Francis N, Hatfield J, Sullivan JK, et al. Long-term voluntary wheel running does not alter vascular amyloid burden but reduces neuroinflammation in the Tg-SwDI mouse model of cerebral amyloid angiopathy. J Neuroinflammation. 2019;16(1):144.","journal-title":"J Neuroinflammation"},{"issue":"10","key":"536_CR8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1532-5415.1998.tb04537.x","volume":"46","author":"H White","year":"1998","unstructured":"White H, Pieper C, Schmader K. The association of weight change in Alzheimer\u2019s disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc. 1998;46(10):1223\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"78","key":"536_CR9","doi-asserted-by":"crossref","first-page":"34691","DOI":"10.18632\/oncotarget.26162","volume":"9","author":"J Pegueroles","year":"2018","unstructured":"Pegueroles J, Jim\u00e9nez A, Vilaplana E, Montal V, Carmona-Iragui M, Pan\u00e9 A, et al. Obesity and Alzheimer\u2019s disease, does the obesity paradox really exist? A magnetic resonance imaging study. Oncotarget. 2018;9(78):34691\u20138.","journal-title":"Oncotarget"},{"key":"536_CR10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neurobiolaging.2020.03.002","volume":"93","author":"JS Rabin","year":"2020","unstructured":"Rabin JS, Shirzadi Z, Swardfager W, MacIntosh BJ, Schultz A, Yang H-S, et al. Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults. Neurobiol Aging. 2020;93:124\u201330.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"536_CR11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.3233\/JAD-150987","volume":"53","author":"DC Hsu","year":"2016","unstructured":"Hsu DC, Mormino EC, Schultz AP, Amariglio RE, Donovan NJ, Rentz DM, et al. Lower late-life body-mass index is associated with higher cortical amyloid burden in clinically normal elderly. J Alzheimer\u2019s Dis JAD. 2016;53(3):1097\u2013105.","journal-title":"J Alzheimer\u2019s Dis JAD"},{"issue":"3","key":"536_CR12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151710","volume":"11","author":"I Cova","year":"2016","unstructured":"Cova I, Clerici F, Rossi A, Cucumo V, Ghiretti R, Maggiore L, et al. Weight loss predicts progression of mild cognitive impairment to Alzheimer\u2019s disease. PLoS ONE. 2016;11(3): e0151710.","journal-title":"PLoS ONE"},{"issue":"8","key":"536_CR13","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.neurobiolaging.2011.05.005","volume":"33","author":"M Ewers","year":"2012","unstructured":"Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, et al. Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(8):1599\u2013608.","journal-title":"Neurobiol Aging"},{"key":"536_CR14","doi-asserted-by":"crossref","first-page":"100944","DOI":"10.1016\/j.arr.2019.100944","volume":"55","author":"M Xue","year":"2019","unstructured":"Xue M, Xu W, Ou Y-N, Cao X-P, Tan M-S, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"536_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2174\/156720507780362047","volume":"4","author":"RA Whitmer","year":"2007","unstructured":"Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007;4(2):103\u20139.","journal-title":"Curr Alzheimer Res"},{"key":"536_CR16","doi-asserted-by":"crossref","unstructured":"Beeri MS, Tirosh A, Lin HM, Golan S, Boccara E, Sano M, et al. Stability in BMI over time is associated with a better cognitive trajectory in older adults. Alzheimers Dement. 2022.","DOI":"10.1002\/alz.057574"},{"issue":"11","key":"536_CR17","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/jgs.16814","volume":"68","author":"AT Aiken-Morgan","year":"2020","unstructured":"Aiken-Morgan AT, Capuano AW, Arvanitakis Z, Barnes LL. Changes in body mass index are related to faster cognitive decline among African American older adults. J Am Geriatr Soc. 2020;68(11):2662\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"536_CR18","first-page":"483","volume":"49","author":"BS Ye","year":"2016","unstructured":"Ye BS, Jang EY, Kim SY, Kim EJ, Park SA, Lee Y, et al. Unstable body mass index and progression to probable Alzheimer\u2019s disease dementia in patients with amnestic mild cognitive impairment. J Alzheimers Dis. 2016;49(2):483\u201391.","journal-title":"J Alzheimers Dis"},{"issue":"3\u20134","key":"536_CR19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000444216","volume":"41","author":"I Cova","year":"2016","unstructured":"Cova I, Clerici F, Maggiore L, Pomati S, Cucumo V, Ghiretti R, et al. Body mass index predicts progression of mild cognitive impairment to dementia. Dement Geriatr Cogn Disord. 2016;41(3\u20134):172\u201380.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"536_CR20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/jamaneurol.2021.4161","volume":"79","author":"S Salloway","year":"2021","unstructured":"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, et al. Amyloid-related imaging abnormalities in 2 phase 3 studies evaluating aducanumab in patients with early Alzheimer disease. JAMA Neurol. 2021;79:13.","journal-title":"JAMA Neurol"},{"issue":"4","key":"536_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1567205010666131120110930","volume":"11","author":"Y Gu","year":"2014","unstructured":"Gu Y, Scarmeas N, Cosentino S, Brandt J, Albert M, Blacker D, et al. Change in body mass index before and after Alzheimer\u2019s disease onset. Curr Alzheimer Res. 2014;11(4):349\u201356.","journal-title":"Curr Alzheimer Res"},{"issue":"9","key":"536_CR22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.63.9.1312","volume":"63","author":"DK Johnson","year":"2006","unstructured":"Johnson DK, Wilkins CH, Morris JC. Accelerated weight loss may precede diagnosis in Alzheimer disease. Arch Neurol. 2006;63(9):1312\u20137.","journal-title":"Arch Neurol"},{"issue":"1","key":"536_CR23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41598-017-01327-w","volume":"7","author":"S M\u00fcller","year":"2017","unstructured":"M\u00fcller S, Preische O, Sohrabi HR, Gr\u00e4ber S, Jucker M, Dietzsch J, et al. Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer\u2019s disease. Sci Rep. 2017;7(1):1225.","journal-title":"Sci Rep"},{"issue":"7","key":"536_CR24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00259-002-0816-3","volume":"29","author":"DJ Callen","year":"2002","unstructured":"Callen DJ, Black SE, Caldwell CB. Limbic system perfusion in Alzheimer\u2019s disease measured by MRI-coregistered HMPAO SPET. Eur J Nucl Med Mol Imaging. 2002;29(7):899\u2013906.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"536_CR25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.neurobiolaging.2003.08.011","volume":"25","author":"DJ Callen","year":"2004","unstructured":"Callen DJ, Black SE, Caldwell CB, Grady CL. The influence of sex on limbic volume and perfusion in AD. Neurobiol Aging. 2004;25(6):761\u201370.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"536_CR26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/WNL.57.9.1669","volume":"57","author":"DJ Callen","year":"2001","unstructured":"Callen DJ, Black SE, Gao F, Caldwell CB, Szalai JP. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology. 2001;57(9):1669\u201374.","journal-title":"Neurology"},{"issue":"4","key":"536_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jalz.2008.04.005","volume":"4","author":"AM Hall","year":"2008","unstructured":"Hall AM, Moore RY, Lopez OL, Kuller L, Becker JT. Basal forebrain atrophy is a presymptomatic marker for Alzheimer\u2019s disease. Alzheimers Dement. 2008;4(4):271\u20139.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"536_CR28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2967\/jnumed.112.116558","volume":"54","author":"DJ Cross","year":"2013","unstructured":"Cross DJ, Anzai Y, Petrie EC, Martin N, Richards TL, Maravilla KR, et al. Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. J Nucl Med. 2013;54(8):1278\u201384.","journal-title":"J Nucl Med"},{"issue":"18","key":"536_CR29","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1212\/WNL.98.18_supplement.2382","volume":"98","author":"A Tao","year":"2022","unstructured":"Tao A, Myslinski Z, Pan Y, Iadecola C, Dyke J, Chiang G, et al. Longitudinal hypothalamic atrophy and its association with amyloid-\u03b2 and tau pathology in Alzheimer\u2019s disease (P9\u20133.004). Neurology. 2022;98(18):2382.","journal-title":"Neurology"},{"issue":"1","key":"536_CR30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbadis.2017.10.028","volume":"1864","author":"H Zheng","year":"2018","unstructured":"Zheng H, Zhou Q, Du Y, Li C, Xu P, Lin L, et al. The hypothalamus as the primary brain region of metabolic abnormalities in APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) Mol Basis Dis. 2018;1864(1):263\u201373.","journal-title":"Biochimica et Biophysica Acta (BBA) Mol Basis Dis."},{"issue":"10","key":"536_CR31","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.3390\/ijms22105365","volume":"22","author":"AJ L\u00f3pez-Gambero","year":"2021","unstructured":"L\u00f3pez-Gambero AJ, Rosell-Valle C, Medina-Vera D, Navarro JA, Vargas A, Rivera P, et al. A negative energy balance is associated with metabolic dysfunctions in the hypothalamus of a humanized preclinical model of Alzheimer\u2019s disease, the 5XFAD mouse. Int J Mol Sci. 2021;22(10):5365.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"536_CR32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jalz.2016.01.008","volume":"12","author":"HH Ruiz","year":"2016","unstructured":"Ruiz HH, Chi T, Shin AC, Lindtner C, Hsieh W, Ehrlich M, et al. Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer\u2019s disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels. Alzheimer\u2019s Dement. 2016;12(8):851\u201361.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"536_CR33","volume":"13","author":"K Do","year":"2018","unstructured":"Do K, Laing BT, Landry T, Bunner W, Mersaud N, Matsubara T, et al. The effects of exercise on hypothalamic neurodegeneration of Alzheimer\u2019s disease mouse model. PLoS ONE. 2018;13(1): e0190205.","journal-title":"PLoS ONE"},{"issue":"1","key":"536_CR34","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12974-020-01956-5","volume":"17","author":"LS Robison","year":"2020","unstructured":"Robison LS, Gannon OJ, Thomas MA, Salinero AE, Abi-Ghanem C, Poitelon Y, et al. Role of sex and high-fat diet in metabolic and hypothalamic disturbances in the 3xTg-AD mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2020;17(1):285.","journal-title":"J Neuroinflammation"},{"issue":"47","key":"536_CR35","doi-asserted-by":"crossref","first-page":"11817","DOI":"10.1523\/JNEUROSCI.1390-16.2016","volume":"36","author":"RM Shansky","year":"2016","unstructured":"Shansky RM, Woolley CS. Considering sex as a biological variable will be valuable for neuroscience research. J Neurosci. 2016;36(47):11817\u201322.","journal-title":"J Neurosci"},{"key":"536_CR36","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2019.100817","volume":"56","author":"LA Galea","year":"2020","unstructured":"Galea LA, Choleris E, Albert AY, McCarthy MM, Sohrabji F. The promises and pitfalls of sex difference research. Front Neuroendocrinol. 2020;56: 100817.","journal-title":"Front Neuroendocrinol"},{"issue":"8","key":"536_CR37","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.nrl.2016.02.016","volume":"32","author":"H Niu","year":"2017","unstructured":"Niu H, \u00c1lvarez-\u00c1lvarez I, Guill\u00e9n-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer\u2019s disease in Europe: a meta-analysis. Neurologia. 2017;32(8):523\u201332.","journal-title":"Neurologia"},{"issue":"3","key":"536_CR38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jalz.2019.01.010","volume":"15","author":"A As","year":"2019","unstructured":"As A. 2019 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2019;15(3):321\u201387.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"12","key":"536_CR39","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/j.euroneuro.2014.06.008","volume":"24","author":"SM de la Monte","year":"2014","unstructured":"de la Monte SM. Type 3 diabetes is sporadic Alzheimer\u2019s disease: mini-review. Eur Neuropsychopharmacol. 2014;24(12):1954\u201360.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"10","key":"536_CR40","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1038\/s41380-021-01068-3","volume":"26","author":"W-I Ryu","year":"2021","unstructured":"Ryu W-I, Bormann MK, Shen M, Kim D, Forester B, Park Y, et al. Brain cells derived from Alzheimer\u2019s disease patients have multiple specific innate abnormalities in energy metabolism. Mol Psychiatry. 2021;26(10):5702\u201314.","journal-title":"Mol Psychiatry"},{"key":"536_CR41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.nbd.2019.03.008","volume":"127","author":"A Adlimoghaddam","year":"2019","unstructured":"Adlimoghaddam A, Snow WM, Stortz G, Perez C, Djordjevic J, Goertzen AL, et al. Regional hypometabolism in the 3xTg mouse model of Alzheimer\u2019s disease. Neurobiol Dis. 2019;127:264\u201377.","journal-title":"Neurobiol Dis"},{"key":"536_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.irn.2019.03.001","volume":"145","author":"BC Albensi","year":"2019","unstructured":"Albensi BC. Dysfunction of mitochondria: implications for Alzheimer\u2019s disease. Int Rev Neurobiol. 2019;145:13\u201327.","journal-title":"Int Rev Neurobiol"},{"issue":"6","key":"536_CR43","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/cells9061541","volume":"9","author":"J Djordjevic","year":"2020","unstructured":"Djordjevic J, Roy Chowdhury S, Snow WM, Perez C, Cadonic C, Fernyhough P, et al. Early onset of sex-dependent mitochondrial deficits in the cortex of 3xTg Alzheimer\u2019s mice. Cells. 2020;9(6):1541.","journal-title":"Cells"},{"key":"536_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth BJ, Craft S. Insulin resistance and Alzheimer\u2019s disease: bioenergetic linkages. Front Aging Neurosci. 2017;9:345.","journal-title":"Front Aging Neurosci"},{"key":"536_CR45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.exger.2017.07.004","volume":"107","author":"E Croteau","year":"2018","unstructured":"Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, et al. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer\u2019s disease. Exp Gerontol. 2018;107:18\u201326.","journal-title":"Exp Gerontol"},{"issue":"1","key":"536_CR46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29\u201338.","journal-title":"Arch Neurol"},{"key":"536_CR47","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuropharm.2017.11.037","volume":"136","author":"CD Chapman","year":"2018","unstructured":"Chapman CD, Schi\u00f6th HB, Grillo CA, Benedict C. Intranasal insulin in Alzheimer\u2019s disease: food for thought. Neuropharmacology. 2018;136:196\u2013201.","journal-title":"Neuropharmacology"},{"key":"536_CR48","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JAD-161256","volume":"57","author":"S Craft","year":"2017","unstructured":"Craft S, Claxton A, Baker LD, Hanson AJ, Cholerton B, Trittschuh EH, et al. Effects of regular and long-acting insulin on cognition and Alzheimer\u2019s disease biomarkers: a pilot clinical trial. J Alzheimers Dis. 2017;57:1325\u201334.","journal-title":"J Alzheimers Dis"},{"key":"536_CR49","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.expneurol.2014.06.004","volume":"261","author":"Y Chen","year":"2014","unstructured":"Chen Y, Zhao Y, Dai C-l, Liang Z, Run X, Iqbal K, et al. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces A\u03b2 level and microglia activation in the brains of 3xTg-AD mice. Exp Neurol. 2014;261:610\u20139.","journal-title":"Exp Neurol"},{"issue":"5","key":"536_CR50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/acel.12498","volume":"15","author":"YF Mao","year":"2016","unstructured":"Mao YF, Guo Z, Zheng T, Jiang Y, Yan Y, Yin X, et al. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APP swe\/PS 1dE9 mice. Aging Cell. 2016;15(5):893\u2013902.","journal-title":"Aging Cell"},{"issue":"1","key":"536_CR51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-021-00783-x","volume":"13","author":"MCL Phillips","year":"2021","unstructured":"Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer\u2019s disease. Alzheimer\u2019s Res Therapy. 2021;13(1):51.","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"18","key":"536_CR52","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","volume":"176","author":"JM Perez Ortiz","year":"2019","unstructured":"Perez Ortiz JM, Swerdlow RH. Mitochondrial dysfunction in Alzheimer\u2019s disease: role in pathogenesis and novel therapeutic opportunities. Br J Pharmacol. 2019;176(18):3489\u2013507.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"536_CR73","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles. Neuron. 2003;39(3):409\u201321.","journal-title":"Neuron."},{"issue":"5","key":"536_CR74","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal A\u03b2 Causes the Onset of Early Alzheimer\u2019s Disease-Related Cognitive Deficits in Transgenic Mice. Neuron. 2005;45(5):675\u201388.","journal-title":"Neuron."},{"key":"536_CR53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.steroids.2018.03.004","volume":"135","author":"S Kim","year":"2018","unstructured":"Kim S, Foong D, Cooper MS, Seibel MJ, Zhou H. Comparison of blood sampling methods for plasma corticosterone measurements in mice associated with minimal stress-related artefacts. Steroids. 2018;135:69\u201372.","journal-title":"Steroids"},{"key":"536_CR54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neurobiolaging.2016.04.013","volume":"44","author":"A Joly-Amado","year":"2016","unstructured":"Joly-Amado A, Serraneau KS, Brownlow M, Mar\u00edn de Evsikova C, Speakman JR, Gordon MN, et al. Metabolic changes over the course of aging in a mouse model of\u00a0tau\u00a0deposition. Neurobiology Aging. 2016;44:62\u201373.","journal-title":"Neurobiology Aging."},{"issue":"1","key":"536_CR55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2010.02.003","volume":"33","author":"EM Knight","year":"2012","unstructured":"Knight EM, Verkhratsky A, Luckman SM, Allan SM, Lawrence CB. Hypermetabolism in a triple-transgenic mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2012;33(1):187\u201393.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"536_CR56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13195-020-00687-2","volume":"12","author":"AS Doorduijn","year":"2020","unstructured":"Doorduijn AS, de van Schueren MAE, van de Rest O, de Leeuw FA, Hendriksen HMA, Teunissen CE, et al. Energy intake and expenditure in patients with Alzheimer\u2019s disease and mild cognitive impairment: the NUDAD project. Alzheimer\u2019s Res Therapy. 2020;12(1):116.","journal-title":"Alzheimer\u2019s Res Therapy."},{"issue":"2","key":"536_CR57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13539-010-0015-1","volume":"1","author":"TP Braun","year":"2010","unstructured":"Braun TP, Marks DL. Pathophysiology and treatment of inflammatory anorexia in chronic disease. J Cachexia Sarcopenia Muscle. 2010;1(2):135\u201345.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"536_CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-011-9189-x","volume":"12","author":"S Sisley","year":"2011","unstructured":"Sisley S, Sandoval D. Hypothalamic control of energy and glucose metabolism. Rev Endocr Metab Disord. 2011;12(3):219\u201333.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"536_CR59","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/nbdi.2001.0460","volume":"9","author":"K Niwa","year":"2002","unstructured":"Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis. 2002;9(1):61\u20138.","journal-title":"Neurobiol Dis"},{"key":"536_CR60","doi-asserted-by":"crossref","unstructured":"Gannon OJ, Robison LS, Salinero AE, Abi-Ghanem C, Mansour F, Tyagi A, et al. High fat diet exacerbates cognitive decline in mouse models of Alzheimer\u2019s disease and mixed dementia in a sex-dependent manner. bioRxiv. 2021:2021.10.05.463111.","DOI":"10.1101\/2021.10.05.463111"},{"key":"536_CR61","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3389\/fnins.2018.00739","volume":"12","author":"G Canet","year":"2018","unstructured":"Canet G, Chevallier N, Zussy C, Desrumaux C, Givalois L. Central role of glucocorticoid receptors in Alzheimer\u2019s disease and depression. Front Neurosci. 2018;12:739.","journal-title":"Front Neurosci"},{"issue":"2","key":"536_CR62","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-2012-121438","volume":"33","author":"EK Hebda-Bauer","year":"2013","unstructured":"Hebda-Bauer EK, Simmons TA, Sugg A, Ural E, Stewart JA, Beals JL, et al. 3xTg-AD mice exhibit an activated central stress axis during early-stage pathology. J Alzheimers Dis. 2013;33(2):407\u201322.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"536_CR63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41386-018-0167-9","volume":"44","author":"AL Heck","year":"2019","unstructured":"Heck AL, Handa RJ. Sex differences in the hypothalamic-pituitary-adrenal axis\u2019 response to stress: an important role for gonadal hormones. Neuropsychopharmacology. 2019;44(1):45\u201358.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"536_CR64","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/cphy.c130054","volume":"4","author":"N Goel","year":"2014","unstructured":"Goel N, Workman JL, Lee TT, Innala L, Viau V. Sex differences in the HPA axis. Compr Physiol. 2014;4(3):1121\u201355.","journal-title":"Compr Physiol"},{"issue":"1","key":"536_CR65","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13293-020-00319-2","volume":"11","author":"DG Zuloaga","year":"2020","unstructured":"Zuloaga DG, Heck AL, De Guzman RM, Handa RJ. Roles for androgens in mediating the sex differences of neuroendocrine and behavioral stress responses. Biol Sex Differ. 2020;11(1):44.","journal-title":"Biol Sex Differ"},{"issue":"6","key":"536_CR66","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/eje.0.1490601","volume":"149","author":"DE Laaksonen","year":"2003","unstructured":"Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen T-P, Salonen R, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003;149(6):601\u20138.","journal-title":"Eur J Endocrinol"},{"key":"536_CR67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2018.12.030","volume":"1710","author":"LS Robison","year":"2019","unstructured":"Robison LS, Gannon OJ, Salinero AE, Zuloaga KL. Contributions of sex to cerebrovascular function and pathology. Brain Res. 2019;1710:43\u201360.","journal-title":"Brain Res"},{"issue":"1","key":"536_CR68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-020-00309-4","volume":"11","author":"C Abi-Ghanem","year":"2020","unstructured":"Abi-Ghanem C, Robison LS, Zuloaga KL. Androgens\u2019 effects on cerebrovascular function in health and disease. Biol Sex Differ. 2020;11(1):1\u201318.","journal-title":"Biol Sex Differ"},{"issue":"7","key":"536_CR69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11(7):393\u2013405.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"536_CR70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.yfrne.2013.08.001","volume":"35","author":"JR Rettberg","year":"2014","unstructured":"Rettberg JR, Yao J, Brinton RD. Estrogen: a master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol. 2014;35(1):8\u201330.","journal-title":"Front Neuroendocrinol"},{"issue":"13","key":"536_CR71","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1212\/WNL.0000000000004425","volume":"89","author":"L Mosconi","year":"2017","unstructured":"Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Varsavsky I, et al. Sex differences in Alzheimer risk: brain imaging of endocrine vs chronological aging. Neurology. 2017;89(13):1382\u201390.","journal-title":"Neurology"},{"issue":"2","key":"536_CR72","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1212\/WNL.0000000000009781","volume":"95","author":"A Rahman","year":"2020","unstructured":"Rahman A, Schelbaum E, Hoffman K, Diaz I, Hristov H, Andrews R, et al. Sex-driven modifiers of Alzheimer risk: a multimodality brain imaging study. Neurology. 2020;95(2):e166\u201378.","journal-title":"Neurology"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00536-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-023-00536-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00536-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T14:11:08Z","timestamp":1702908668000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-023-00536-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1186\/s13293-023-00536-5","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"29 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}